在pUL97中马里巴维尔诱导的抑制和耐药性突变机制的分析中,用AlphaFold2预测pUL97的激酶结构
Jocelyne Piret1, Guy Boivin1,2
1Research Center of the CHU de Quebec-Laval University, Quebec City, QC G1V 4G2, Canada.
Viruses
|July 30, 2025
概括
细胞巨乳病毒 (CMV) pUL97激酶突变可能导致对马里巴维 (MBV) 和甘西克洛维 (GCV) 的耐药性. 了解pUL97蛋白质结构中的这些变化有助于开发新的抗病毒疗法.
科学领域:
- 病毒学 病毒学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 细胞巨乳病毒 (CMV) 感染对免疫功能低下的患者构成重大风险.
- 这种pUL97激酶对于CMV复制是必不可少的,也是诸如甘西克洛维 (GCV) 和马里巴维 (MBV) 等抗病毒药物的标.
研究的目的:
- 分析pUL97蛋白质突变,使其对马里巴维尔 (MBV) 产生耐药性和对甘西克洛维尔 (GCV) 产生交叉耐药性.
- 使用计算建模研究MBV和GCV抗性的结构基础.
主要方法:
- 关于pUL97蛋白质结构的AlphaFold2预测.
- 分子对接实验以评估抑制剂结合部位.
- 在pUL97.7中报告的氨基酸替代物的分析.
主要成果:
- 玛丽巴维尔 (MBV) 似乎是一种双位体抑制剂,向ATP结合和基质酸化.
- 仅仅赋予MBV抗性的突变可能会改变ATP结合部位,而不会影响病毒生长.
- 导致MBV和GCV交叉耐药性的替代物会影响催化循环残留物并减少病毒复制.
结论:
- 对pUL97突变的结构洞察对于理解抗病毒耐药性至关重要.
- 这些发现为MBV的临床应用提供了信息,并指导了下一代pUL97激酶抑制剂的设计.
关键词:
在AlphaFold2中,我们将使用AlphaFold2.环普罗巴维尔 环普罗巴维尔 是一种停靠的对接方式药物耐药性 耐药性 药物耐药性甘西克洛维尔 (ganciclovir) 是一种药物.门卫者残留物 门卫者残留物人类细胞巨型病毒玛丽巴维尔是什么意思pUL97 激酶酶的使用方法预测的蛋白质结构.更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.7K
18:10Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
Published on: June 16, 2011
29.7K
相关概念视频
In-vitro Mutagenesis
14.2K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.2K
Protein-Drug Binding: Mechanism and Kinetics
954
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
954
